UBS Maintains Buy on Pactiv Evergreen, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Curt Woodworth maintains a Buy rating on Pactiv Evergreen (NASDAQ:PTVE) but lowers the price target from $16 to $15.

August 08, 2024 | 2:29 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst Curt Woodworth maintains a Buy rating on Pactiv Evergreen but lowers the price target from $16 to $15.
The maintained Buy rating suggests continued confidence in Pactiv Evergreen's long-term prospects, but the lowered price target indicates some caution about short-term performance. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100